These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 483113)

  • 1. An acquired inhibitor to factor XIII A case report.
    Shires L; Gomperts ED; Bradlow BA
    S Afr Med J; 1979 Jul; 56(2):70-2. PubMed ID: 483113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral haemorrhage due to acquired factor XIII inhibitor--successful response to factor XIII concentrate.
    Daly HM; Carson PJ; Smith JK
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):507-14. PubMed ID: 1768763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An acquired inhibitor to factor XIII.
    McDevitt NB; McDonagh J; Taylor HL; Roberts HR
    Arch Intern Med; 1972 Nov; 130(5):772-7. PubMed ID: 5083419
    [No Abstract]   [Full Text] [Related]  

  • 4. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD; Miloszewski KJ; Losowsky MS
    Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
    Krumdieck R; Shaw DR; Huang ST; Poon MC; Rustagi PK
    Am J Med; 1991 May; 90(5):639-45. PubMed ID: 1903026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations.
    Otis PT; Feinstein DI; Rapaport SI; Patch MJ
    Blood; 1974 Dec; 44(6):771-81. PubMed ID: 4214572
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies.
    Sugiyama H; Uesugi H; Suzuki S; Tanaka K; Souri M; Ichinose A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):85-9. PubMed ID: 23183237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII deficiency: pathogenic mechanisms and clinical significance.
    Egbring R; Kröniger A; Seitz R
    Semin Thromb Hemost; 1996; 22(5):419-25. PubMed ID: 8989826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired plasma factor XIII deficiencies.
    Tosetto A; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):5-10. PubMed ID: 8039759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired factor XIII deficiency: a therapeutic challenge.
    Boehlen F; Casini A; Chizzolini C; Mansouri B; Kohler HP; Schroeder V; Reber G; de Moerloose P
    Thromb Haemost; 2013 Mar; 109(3):479-87. PubMed ID: 23306660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure.
    Luo Y; Zhang G; Zuo W; Zheng W; Dai C
    Ann Hematol; 2010 Aug; 89(8):833-4. PubMed ID: 19953252
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
    Anders O; Görss EW; Ernst B; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).
    Lorand L; Maldonado N; Fradera J; Atencio AC; Robertson B; Urayama T
    Br J Haematol; 1972 Jul; 23(1):17-27. PubMed ID: 5045959
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination.
    Luo YY; Zhang GS
    Haemophilia; 2011 May; 17(3):393-8. PubMed ID: 21323797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway Compromise and Perioperative Management of a Patient with Acquired Factor XIII Inhibitor.
    Tone K; Lalu M; Kilty SJ; Rosenberg E; Tinmouth A
    A A Case Rep; 2015 May; 4(9):120-4. PubMed ID: 25909777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide.
    Nakamura S; Kato A; Sakata Y; Aoki N
    Br J Haematol; 1988 Mar; 68(3):313-9. PubMed ID: 3258529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin-stabilizing factor inhibitors. IX. An inhibitor assay method based on SDS-disc gel electrophoresis.
    Hoffmann KJ; Ljunggren C; Stenberg P; Nilsson JL
    Acta Pharm Suec; 1973 Sep; 10(4):269-76. PubMed ID: 4759353
    [No Abstract]   [Full Text] [Related]  

  • 19. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.